Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1962 clinical trials
Featured trial
Chronic Heart Failure – Ages 18-85

Chronic Heart Failure – Ages 18-85

  • 170 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Type 2 Diabetes - patients after an Acute Coronary Syndrome

Type 2 Diabetes - patients after an Acute Coronary Syndrome

  • 4 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Type 2 Diabetes and Cardiovascular Disease

Type 2 Diabetes and Cardiovascular Disease

  • 108 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Need a Cardiac Stent?

Need a Cardiac Stent?

  • 324 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Type 2 Diabetes with Cardiovascular Risk – Ages 40+

Type 2 Diabetes with Cardiovascular Risk – Ages 40+

  • 250 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease

  • 87 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

  • 258 views
  • 08 Dec, 2020
  • 1 location
Featured trial
A Phase Ii, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro4602522 Added To The Background Therapy Of The Acetylcholinesterase Inhibitors Donepezil Or Rivastigmine In Patients With Moderate Severity Alzheimer's Disease

A Phase Ii, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Ro4602522 Added To The Background Therapy Of The Acetylcholinesterase Inhibitors Donepezil Or Rivastigmine In Patients With Moderate Severity Alzheimer's Disease

  • 174 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Alzheimer’s Disease Research Center (ADRC) Longitudinal Study

This study is looking for people with mild cognitive impairment, young-onset Alzheimer’s, frontotemporal dementia, or Lewy body dementia. The study is also looking for cognitively-normal people over the age of 65, as a comparison. The study will follow the progression of various dementias to help with early detection, accurate diagnosis, …

stroke
Accepts healthy volunteers
cancer
mild cognitive impairment
cognitive impairment
  • 218 views
  • 25 Jan, 2022
  • 1 location
Featured trial
New Approaches to Dementia Heterogeneity.

This study is looking for adults who have mild cognitive impairment, Alzheimer’s, or other forms of dementia. The study is also looking for people with normal cognition, as a comparison. The study is interested in the ways that brain function changes over time with the goal of improving the ability to diagnose …

stroke
heart disease
cancer
dementia, frontotemporal
multiple sclerosis
  • 160 views
  • 25 May, 2021
  • 1 location